Infectious prions accumulate to high levels in non proliferative C2C12 myotubes

Allen Herbst1, Pamela Banser, Camilo Duque Velasquez

  • 1Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada ; Department of Agriculture, Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta, Canada.

Plos Pathogens
|November 19, 2013
PubMed

Insights

Non-replicating muscle myotubes efficiently accumulate high levels of infectious prions (PrP(Sc)), approaching in vivo levels. This novel model system is valuable for studying prion diseases and screening anti-prion compounds.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Prion diseases involve the misfolding of cellular prion protein (PrP(C)) into infectious PrP(Sc).
  • Traditional cell culture models yield low prion accumulation, limiting their utility.
  • Non-replicating cells offer a potential for higher prion levels and infectivity.

Purpose of the Study:

  • To investigate the utility of non-proliferating muscle myotubes as a model for prion infection.
  • To quantify PrP(Sc) accumulation and infectivity in these cells.
  • To assess prion strain specificity and species barrier effects in myotubes.

Main Methods:

  • Differentiated myoblasts were cultured into non-proliferating myotubes.
  • Myotubes were infected with mouse-adapted prion agents.
  • PrP(Sc) levels and infectivity (L.D.50/mg) were measured.
  • Infection with different prion strains and species was tested.

Main Results:

  • Prion-infected myotubes generated substantial PrP(Sc) and high infectivity levels (10(5.5) L.D.50/mg).
  • Myotubes demonstrated strain-specific prion replication.
  • Mouse myotubes were resistant to hamster prions, indicating an intact species barrier.

Conclusions:

  • Non-proliferating myotubes are a robust model for generating infectious prions.
  • This model system can be used for screening anti-prion drug candidates.
  • Myotube cultures provide valuable insights into prion disease mechanisms.